|
Press Contacts
Bo Piela
Senior Director, Corporate Communications
Phone: 617-768-6579
Corporate/executive issues; Financial results; Manufacturing/facilities; International issues; Public policy; Genetic diseases (Cerezyme, Fabrazyme, Aldurazyme, Myozyme) and Transplant (Thymoglobulin, Mozobil).
|
Erin Emlock
Associate Manager, Corporate Communications
Phone: 617-768-6923
Renal disease (Renagel, Renvela, Hectorol); Endocrinology (Thyrogen); Diagnostics (point-of-care testing); Cardiovascular (Cholestagel, WelChol and mipomersen) and HR topics.
|
Sarah Millerick
Senior Corporate Communications Specialist
Phone: 617-768-6438
Cell therapies (Carticel and Epicel); Biosurgical specialties (Seprafilm); Genetics (reproductive and cancer testing) and Community Relations.
|
Heidi De Wit
Director, Corporate Affairs Europe
Phone: +32 2 714 17 42
|
Caroline De Bie
Corporate Communication Manager, Europe
Phone: +32 2 714 17 45
|
If you would prefer to send an email please contact Media Relations.
If you are not a journalist and are calling with a general question about Genzyme, please call our main phone number:
617-252-7500.
|
Home
